These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3857119

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors.
    Chang TT, Gulati S, Chou TC, Colvin M, Clarkson B.
    Cancer Res; 1987 Jan 01; 47(1):119-22. PubMed ID: 3466686
    [Abstract] [Full Text] [Related]

  • 3. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM, Gulati SC.
    Exp Hematol; 1990 Oct 01; 18(9):1008-12. PubMed ID: 2397748
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Tamayo E, Hervé P.
    Exp Hematol; 1988 Feb 01; 16(2):97-101. PubMed ID: 3276544
    [Abstract] [Full Text] [Related]

  • 7. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
    Chao NJ, Aihara M, Blume KG, Sikic BI.
    Exp Hematol; 1990 Dec 01; 18(11):1193-8. PubMed ID: 2226679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
    Miller G, Brashear T, Stone M, Fay J.
    Int J Cell Cloning; 1991 Sep 01; 9(5):503-10. PubMed ID: 1955738
    [Abstract] [Full Text] [Related]

  • 11. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM.
    Exp Hematol; 1993 Dec 01; 21(13):1663-7. PubMed ID: 8243568
    [Abstract] [Full Text] [Related]

  • 12. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
    Lemoli RM, Gasparetto C, Scheinberg DA, Moore MA, Clarkson BD, Gulati SC.
    Blood; 1991 Apr 15; 77(8):1829-36. PubMed ID: 2015406
    [Abstract] [Full Text] [Related]

  • 13. In vitro evaluation of combination drug purging for autologous bone marrow transplantation.
    Jones RJ, Miller CB, Zehnbauer BA, Rowley SD, Colvin OM, Sensenbrenner LL.
    Bone Marrow Transplant; 1990 May 15; 5(5):301-7. PubMed ID: 2350626
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P, Pulsoni A, Sandrelli A, Simone F, Amadori S, Meloni G, Mandelli F.
    Bone Marrow Transplant; 1987 Oct 15; 2(3):287-98. PubMed ID: 3502785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2000 Oct 15; 26(7):711-6. PubMed ID: 11042650
    [Abstract] [Full Text] [Related]

  • 18. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemia.
    Zander AR, Vellekoop L, Spitzer G, Verma DS, Litam J, McCredie KB, Keating M, Hester JP, Dicke KA.
    Cancer Treat Rep; 1981 Jul 15; 65(5-6):377-81. PubMed ID: 7016323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.